ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
23.95
-0.89 (-3.60%)
Sep 10, 2025, 2:35 PM - Market open

ACADIA Pharmaceuticals Stock Forecast

Stock Price Forecast

The 19 analysts that cover ACADIA Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $28.79, which forecasts a 20.23% increase in the stock price over the next year. The lowest target is $17 and the highest is $40.

Price Target: $28.79 (+20.23%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$17$28.79$28$40
Change-29.00%+20.23%+16.93%+67.05%

Analyst Ratings

The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy444444
Buy568788
Hold867777
Sell000000
Strong Sell000011
Total171619182020

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Strong Buy
Maintains
$36$39
Strong BuyMaintains$36$39+62.87%Sep 9, 2025
UBS
UBS
Strong Buy
Maintains
$32$36
Strong BuyMaintains$32$36+50.34%Aug 8, 2025
Goldman Sachs
Goldman Sachs
Strong Sell
Maintains
$15$17
Strong SellMaintains$15$17-29.00%Aug 7, 2025
RBC Capital
RBC Capital
Buy
Maintains
$39$40
BuyMaintains$39$40+67.05%Aug 7, 2025
JMP Securities
JMP Securities
Buy
Maintains
$30$35
BuyMaintains$30$35+46.17%Aug 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.09B
from 957.80M
Increased by 14.01%
Revenue Next Year
1.22B
from 1.09B
Increased by 11.72%
EPS This Year
0.58
from 1.36
Decreased by -57.65%
EPS Next Year
0.86
from 0.58
Increased by 50.00%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
441.76M484.15M517.24M726.44M957.80M1.09B1.22B
Revenue Growth
30.28%9.60%6.83%40.45%31.85%14.01%11.72%
EPS
-1.79-1.05-1.34-0.371.360.580.86
EPS Growth
------57.65%50.00%
Forward PE
-----41.5827.72
No. Analysts
-----2222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High1.1B1.4B
Avg1.1B1.2B
Low1.0B1.1B

Revenue Growth

Revenue Growth20252026202720282029
High
19.3%
27.6%
Avg
14.0%
11.7%
Low
8.0%
1.5%

EPS Forecast

EPS20252026202720282029
High1.072.03
Avg0.580.86
Low0.360.44

EPS Growth

EPS Growth20252026202720282029
High
-21.2%
251.9%
Avg
-57.7%
50.0%
Low
-73.3%
-23.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.